Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_2847844
Proper Citation: Abcam Cat# ab272854, RRID:AB_2847844
Target Antigen: spike glycoprotein - Chimeric
Host Organism: mouse
Clonality: recombinant
Comments:
Validation: COVID validation complete PsyENCODE for ELISA; Applications: ELISA
Info: Recombinant human/mouse chimeric monoclonal antibody consisting of Mouse scFv fused with human IgG1. As the Fc region is human, an anti-Human secondary antibody should be used for detection.
We found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Recombinant Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Chimeric.
No alerts have been found for Recombinant Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Chimeric.
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.